We recently published a list of 10 Best Falling Stocks to Invest in Right Now. In this article, we are going to take a look ...

UBS analyst Jo Walton maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK750.00. The company’s ...

Equities research analysts at Cantor Fitzgerald decreased their FY2024 earnings per share (EPS) estimates for Novo Nordisk ...

Novo Nordisk has faced several challenges recently ... Guggenheim Securities held a Buy rating and raised the price target slightly. UBS upgraded the company's stock from a Sell to a Buy rating ...

BMO Capital Markets affirmed their positive stance on Novo Nordisk (NYSE:NVO) stock, maintaining both their Outperform rating and a $105.00 price target. The endorsement comes in the wake of promising ...

UBS upgraded the company's stock from a Sell to a Buy rating, while Bernstein revised its rating from 'Underperform' to 'Market Perform'. These evaluations follow recent developments, including the ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

European companies are set to deliver a third straight quarter of profit growth, which may help to maintain newfound investor ...

Find insight on Novo Nordisk Foundation, ResMed, Johnson & Johnson, and more in the latest Market Talks covering Health Care.

Nvidia stock is higher Tuesday after President Trump revoked a 2023 executive order targeting AI developers. Here's what we ...